Clinical Trial Update: Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy

View source ↗

Summary

This clinical trial update reports long-term follow-up of RGX-314 administered in the suprachoroidal space for participants with diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• RGX-314

Snippet

Sponsor: AbbVie | Conditions: Diabetic Retinopathy, DR | Status: ENROLLING_BY_INVITATION